Mouwasat Medical Services Past Earnings Performance
Past criteria checks 2/6
Mouwasat Medical Services has been growing earnings at an average annual rate of 9.1%, while the Healthcare industry saw earnings growing at 20.3% annually. Revenues have been growing at an average rate of 9.2% per year. Mouwasat Medical Services's return on equity is 19.3%, and it has net margins of 22.7%.
Key information
9.1%
Earnings growth rate
9.1%
EPS growth rate
| Healthcare Industry Growth | 12.3% |
| Revenue growth rate | 9.2% |
| Return on equity | 19.3% |
| Net Margin | 22.7% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing
Dec 12
Do Mouwasat Medical Services' (TADAWUL:4002) Earnings Warrant Your Attention?
Sep 30The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing
Sep 12Mouwasat Medical Services Company's (TADAWUL:4002) Popularity With Investors Is Clear
Aug 06Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?
Jul 01Mouwasat Medical Services Company's (TADAWUL:4002) Popularity With Investors Is Clear
Apr 23Here's Why We Think Mouwasat Medical Services (TADAWUL:4002) Might Deserve Your Attention Today
Mar 18Slowing Rates Of Return At Mouwasat Medical Services (TADAWUL:4002) Leave Little Room For Excitement
Jan 23Here's Why Mouwasat Medical Services (TADAWUL:4002) Has Caught The Eye Of Investors
Dec 17Mouwasat Medical Services (TADAWUL:4002) Has Some Way To Go To Become A Multi-Bagger
Oct 05Should You Be Adding Mouwasat Medical Services (TADAWUL:4002) To Your Watchlist Today?
Sep 17The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing
Jul 03Is Now The Time To Put Mouwasat Medical Services (TADAWUL:4002) On Your Watchlist?
Jun 12Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down
Feb 24Mouwasat Medical Services Company's (TADAWUL:4002) Intrinsic Value Is Potentially 25% Below Its Share Price
Jan 18Return Trends At Mouwasat Medical Services (TADAWUL:4002) Aren't Appealing
Nov 24Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down
Aug 24A Look At The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Jul 01Time To Worry? Analysts Just Downgraded Their Mouwasat Medical Services Company (TADAWUL:4002) Outlook
May 23Mouwasat Medical Services (TADAWUL:4002) Will Pay A Larger Dividend Than Last Year At ر.س2.75
Apr 29Mouwasat Medical Services (TADAWUL:4002) Is Increasing Its Dividend To ر.س2.75
Apr 15Investors Will Want Mouwasat Medical Services' (TADAWUL:4002) Growth In ROCE To Persist
Mar 17Calculating The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Mar 02If You Like EPS Growth Then Check Out Mouwasat Medical Services (TADAWUL:4002) Before It's Too Late
Feb 15The Return Trends At Mouwasat Medical Services (TADAWUL:4002) Look Promising
Dec 06Do Mouwasat Medical Services's (TADAWUL:4002) Earnings Warrant Your Attention?
Nov 16Mouwasat Medical Services (TADAWUL:4002) Is Achieving High Returns On Its Capital
Aug 29Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?
Aug 12Is Mouwasat Medical Services Company (TADAWUL:4002) Expensive For A Reason? A Look At Its Intrinsic Value
Jun 29Mouwasat Medical Services' (TADAWUL:4002) Returns On Capital Are Heading Higher
May 26Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?
May 11Is It Worth Buying Mouwasat Medical Services Company (TADAWUL:4002) For Its 1.4% Dividend Yield?
Apr 13Estimating The Intrinsic Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Mar 16Is Mouwasat Medical Services Company's (TADAWUL:4002) Latest Stock Performance Being Led By Its Strong Fundamentals?
Mar 02Is Mouwasat Medical Services (TADAWUL:4002) A Future Multi-bagger?
Feb 13Here's Why I Think Mouwasat Medical Services (TADAWUL:4002) Is An Interesting Stock
Feb 01
What Kind Of Shareholders Hold The Majority In Mouwasat Medical Services Company's (TADAWUL:4002) Shares?
Jan 17What Makes Mouwasat Medical Services Company (TADAWUL:4002) A Great Dividend Stock?
Jan 04Mouwasat Medical Services (TADAWUL:4002) Has Gifted Shareholders With A Fantastic 137% Total Return On Their Investment
Dec 21Estimating The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Dec 08Mouwasat Medical Services Company's (TADAWUL:4002) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
Nov 24Revenue & Expenses Breakdown
How Mouwasat Medical Services makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2,897 | 658 | 613 | 0 |
| 30 Jun 24 | 2,827 | 665 | 576 | 0 |
| 31 Mar 24 | 2,764 | 663 | 564 | 0 |
| 31 Dec 23 | 2,706 | 658 | 547 | 0 |
| 30 Sep 23 | 2,593 | 659 | 472 | 0 |
| 30 Jun 23 | 2,501 | 625 | 464 | 0 |
| 31 Mar 23 | 2,431 | 616 | 446 | 0 |
| 31 Dec 22 | 2,334 | 599 | 419 | 0 |
| 30 Sep 22 | 2,226 | 561 | 396 | 0 |
| 30 Jun 22 | 2,208 | 581 | 383 | 0 |
| 31 Mar 22 | 2,177 | 581 | 372 | 0 |
| 31 Dec 21 | 2,144 | 578 | 360 | 0 |
| 30 Sep 21 | 2,125 | 574 | 369 | 0 |
| 30 Jun 21 | 2,143 | 593 | 373 | 0 |
| 31 Mar 21 | 2,085 | 567 | 369 | 0 |
| 31 Dec 20 | 2,045 | 528 | 371 | 0 |
| 30 Sep 20 | 2,016 | 515 | 364 | 0 |
| 30 Jun 20 | 1,911 | 447 | 355 | 0 |
| 31 Mar 20 | 1,889 | 422 | 357 | 0 |
| 31 Dec 19 | 1,857 | 421 | 349 | 0 |
| 30 Sep 19 | 1,808 | 376 | 367 | 0 |
| 30 Jun 19 | 1,769 | 364 | 370 | 0 |
| 31 Mar 19 | 1,717 | 361 | 367 | 0 |
| 31 Dec 18 | 1,677 | 360 | 361 | 0 |
| 30 Sep 18 | 1,652 | 373 | 359 | 0 |
| 30 Jun 18 | 1,608 | 369 | 345 | 0 |
| 31 Mar 18 | 1,567 | 358 | 337 | 0 |
| 31 Dec 17 | 1,507 | 337 | 334 | 0 |
| 30 Sep 17 | 1,435 | 314 | 318 | 0 |
| 30 Jun 17 | 1,356 | 286 | 307 | 0 |
| 31 Mar 17 | 1,303 | 274 | 296 | 0 |
| 31 Dec 16 | 1,243 | 257 | 284 | 0 |
| 30 Sep 16 | 1,144 | 235 | 254 | 0 |
| 30 Jun 16 | 1,095 | 229 | 236 | 0 |
| 31 Mar 16 | 1,050 | 221 | 220 | 0 |
| 31 Dec 15 | 1,000 | 209 | 209 | 0 |
| 30 Sep 15 | 926 | 206 | 157 | 0 |
| 30 Jun 15 | 925 | 235 | 167 | 0 |
| 31 Mar 15 | 914 | 238 | 175 | 0 |
| 31 Dec 14 | 904 | 240 | 179 | 0 |
| 30 Sep 14 | 961 | 240 | 245 | 0 |
| 30 Jun 14 | 942 | 212 | 242 | 0 |
| 31 Mar 14 | 927 | 207 | 238 | 0 |
| 31 Dec 13 | 902 | 201 | 229 | 0 |
Quality Earnings: 4002 has high quality earnings.
Growing Profit Margin: 4002's current net profit margins (22.7%) are lower than last year (25.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4002's earnings have grown by 9.1% per year over the past 5 years.
Accelerating Growth: 4002's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 4002 had negative earnings growth (-0.1%) over the past year, making it difficult to compare to the Healthcare industry average (13.5%).
Return on Equity
High ROE: 4002's Return on Equity (19.3%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 23:40 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Mouwasat Medical Services Company is covered by 22 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jassim Al-Jubran | Aljazira Capital Company |
| Rim Ben Salah Gharbi | AlphaMena |
| Kais Kriaa | AlphaMena |